Hatfield Jeffrey S. 4
4 · aTYR PHARMA INC · Filed May 17, 2018
Insider Transaction Report
Form 4
aTYR PHARMA INCLIFE
Hatfield Jeffrey S.
Director
Transactions
- Award
Stock Option (right to buy)
2018-05-15+20,000→ 20,000 totalExercise: $1.35Exp: 2028-05-15→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]The option, granted pursuant to the Issuer's non-employee director compensation policy, vests in full on the earlier of (i) May 15, 2019 or (ii) the Issuer's 2019 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors.